Sitemap| IFCR in pact for collaborative research |
|
Kochi, Sept. 9 IFCR India, an organisation in clinical research and training, has signed an MoU with Cellceutix and KARD Scientific for collaborative research. The CMD of IFCR India, Mr Anil Joseph, handed over the signed MoU to Dr Krishna Menon, founder President of Cellceutix, USA and President of KARD Scientific USA. The collaborators believe that this will fill the gap between the expectations of the patients and the scientific aid available. Mr Menon's works are focussed on cancer research and had led to the development of the anti-cancer compounds Cryptophycin and blockbuster drugs Alimta and Gemzar. - Our Bureau Original article can be viewed here. |